Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,116,701
-
Share change
-
+478,727
-
Total reported value
-
$4,676,750
-
Price per share
-
$1.50
-
Number of holders
-
20
-
Value change
-
+$717,899
-
Number of buys
-
10
-
Number of sells
-
3
Institutional Holders of VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) as of Q4 2018
As of 31 Dec 2018,
VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,116,701 shares.
The largest 10 holders included
SPHERA FUNDS MANAGEMENT LTD., Vanguard Group Inc, Ibex Investors LLC, GEODE CAPITAL MANAGEMENT, LLC, LADENBURG THALMANN FINANCIAL SERVICES INC., D.A. DAVIDSON & CO., NORTHERN TRUST CORP, Parallax Volatility Advisers, L.P., HighTower Advisors, LLC, and OXFORD ASSET MANAGEMENT LLP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.